Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
429.54
-8.19 (-1.87%)
Dec 2, 2025, 4:00 PM EST - Market closed
Chemed Market Cap
Chemed has a market cap or net worth of $6.06 billion as of December 2, 2025. Its market cap has decreased by -28.39% in one year.
Market Cap
6.06B
Enterprise Value
6.07B
1-Year Change
-28.39%
Ranking
Category
Stock Price
$429.54
Market Cap Chart
Since December 1, 1998, Chemed's market cap has increased from $321.30M to $6.06B, an increase of 1,786.19%. That is a compound annual growth rate of 11.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 6.20B | -21.89% |
| Dec 31, 2024 | 7.94B | -9.88% |
| Dec 29, 2023 | 8.81B | 16.04% |
| Dec 30, 2022 | 7.59B | -6.81% |
| Dec 31, 2021 | 8.14B | -4.14% |
| Dec 31, 2020 | 8.50B | 20.82% |
| Dec 31, 2019 | 7.03B | 55.03% |
| Dec 31, 2018 | 4.54B | 16.90% |
| Dec 29, 2017 | 3.88B | 49.09% |
| Dec 30, 2016 | 2.60B | 2.93% |
| Dec 31, 2015 | 2.53B | 40.67% |
| Dec 31, 2014 | 1.80B | 33.04% |
| Dec 31, 2013 | 1.35B | 2.12% |
| Dec 31, 2012 | 1.32B | 29.95% |
| Dec 30, 2011 | 1.02B | -29.66% |
| Dec 31, 2010 | 1.45B | 33.77% |
| Dec 31, 2009 | 1.08B | 21.63% |
| Dec 31, 2008 | 889.70M | -33.46% |
| Dec 31, 2007 | 1.34B | 37.62% |
| Dec 29, 2006 | 971.50M | -24.07% |
| Dec 30, 2005 | 1.28B | 52.89% |
| Dec 31, 2004 | 836.80M | 83.67% |
| Dec 31, 2003 | 455.60M | 31.56% |
| Dec 31, 2002 | 346.30M | 3.90% |
| Dec 31, 2001 | 333.30M | -0.98% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |